Sometimes, for some people. Is magnesium anti-inflammatory for everyone? The trials say no. A 2017 meta-analysis of 11 trials found no drop in CRP overall, but CRP fell in people who started above 3 mg/L. Two later meta-analyses disagreed with each other on CRP.
Why people think magnesium calms inflammation
Magnesium is a mineral your body uses in more than 600 chemical reactions, including the ones that turn food into energy. It is easy to fall short. In the United States, the daily target for adults is about 420 mg for men and 320 mg for women. Around the world, an estimated 2.4 billion people, roughly 31% of everyone, do not reach the recommended amount.
Falling short usually does not feel like anything. A 2018 review noted that a mild shortfall in magnesium usually has no symptoms. But in animal studies, that same mild shortfall primed immune cells to release more inflammatory signals.
People show a pattern too. The same review found that people who eat less magnesium tend to have higher CRP. CRP, or C-reactive protein, is a protein your liver makes when there is inflammation in the body. A CRP of 3 mg/L or more is read as a sign of chronic inflammation, the slow, low-level kind tied to heart disease and diabetes. People with low magnesium intake were more likely to land in that range.
That is a link, not proof. So the real test is a trial: give people magnesium or a placebo and see what happens.
Does magnesium reduce inflammation in the body? The trials split
Three teams have pooled those trials, and they did not agree.
Magnesium lowered CRP in people who started above 3 mg/L, and not in people who started lower.From a 2017 meta-analysis in Curr Pharm Des
A 2022 meta-analysis (a study that combines the results of many trials) looked at 17 randomized trials with 889 people. Their average age was 46. Magnesium lowered CRP compared with placebo, and the trials generally had a low risk of bias.
Another 2022 meta-analysis pooled 18 trials with 927 people. It found no meaningful change in CRP, in IL-6 (another inflammation signal) or in TNF-alpha. The authors concluded their results did not support the idea that magnesium pills improve these markers in adults.
The biggest and newest, from 2026, gathered 78 randomized trials on heart and metabolism risk factors. Magnesium lowered IL-6 a little, by 1.10 pg/mL on average, but it did not change CRP or TNF-alpha. The authors called the effects modest and said their real-world value is uncertain.
Does magnesium only help if your inflammation is high?
Here is where it gets interesting. The 2017 meta-analysis of 11 trials found no CRP drop overall. Then the team split the trials by where people started.
In trials where people began with CRP above 3 mg/L, magnesium lowered CRP by 1.12 mg/L. In trials where people started at 3 mg/L or below, there was no drop. The difference between the two groups was larger than chance would explain.
That fits the idea in the headline question: magnesium may do the most for people who are already off balance. A 2018 review made a similar point. When CRP is high in people with a chronic disease, magnesium pills brought it down.
Low magnesium itself has been tested too, but only in small trials. One trial enrolled 62 adults with prediabetes and low blood magnesium. After 3 months of a daily magnesium drink, the magnesium group had higher blood magnesium and lower hs-CRP (a more sensitive CRP test) than the placebo group.
An earlier pilot from the same research group is a caution. In 26 adults with prediabetes, low magnesium and inflammation, CRP ended lower in the magnesium group than in the placebo group. But within the magnesium group, CRP barely moved from where it started, from 4.1 to 3.3 mg/L. The authors concluded they could not show a benefit.
So does magnesium only help people who are low to begin with? The best answer so far is "maybe, and mostly people with high CRP." No trial in our sources compared people with low and normal magnesium head to head.
What about magnesium from food?
A 2023 study of 1,924 American Indian adults found that how much magnesium people reported eating was not linked to their CRP or IL-6. It measured people at one point in time, so it can show a link or the lack of one, but it cannot prove what drives what.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you have kidney disease, take a diuretic, an acid-reducing pill or any other daily prescription, or are being treated for a heart condition or diabetes.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
The case for magnesium starts with a real gap: a large share of people do not get enough, often without knowing it, and low intake goes along with higher CRP. The trials only partly follow. Pooled together, they disagree. Split by who started with high inflammation, a clearer pattern appears. Magnesium is not a general fix for inflammation. If your CRP is high and your diet is short on whole grains and vegetables, it is worth a conversation and a fair test of a few months.
Common questions
Does magnesium reduce inflammation in the body?
In some trials, yes, but not consistently. A 2022 meta-analysis of 17 trials found lower CRP. Another of 18 trials found no change in CRP, IL-6 or TNF-alpha. A 2026 review of 78 trials found a small drop in IL-6 but none in CRP. The clearest benefit showed up in people whose CRP started above 3 mg/L.
What magnesium dose was used for inflammation?
Most trials in a 2026 review of 78 trials gave 300 mg a day or more, and most ran at least 12 weeks. Few trials tested 500 mg a day or more, or lasted 25 weeks or longer. A separate review found no link between the dose and the change in CRP or IL-6. Ask your doctor what fits you.
Is magnesium glycinate inflammatory?
None of the papers we reviewed suggest that magnesium glycinate raises inflammation. They also did not test glycinate on its own. The trial that lowered hs-CRP in people with low magnesium used magnesium chloride, taken as a daily drink for 3 months. Which form works best for inflammation has not been settled by the studies we found.
Does magnesium lower CRP?
It depends on your starting point. In a 2017 meta-analysis of 11 trials, magnesium lowered CRP by 1.12 mg/L in people who began above 3 mg/L, but not in people at 3 mg/L or below. In a trial of 62 adults with prediabetes and low magnesium, hs-CRP ended lower with magnesium than with placebo.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 10 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 31, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Meta-analysisEffect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M et al. Curr Pharm Des, 2017.PubMedFull paper
- Meta-analysisEffect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials.Veronese N, Pizzol D, Smith L et al. Nutrients, 2022.PubMedFull paper
- Meta-analysisThe Effect of Oral Magnesium Supplementation on Inflammatory Biomarkers in Adults: A Comprehensive Systematic Review and Dose-response Meta-analysis of Randomized Clinical Trials.Talebi S, Miraghajani M, Hosseini R et al. Biol Trace Elem Res, 2022.PubMedFull paper
- Meta-analysisComprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis.Mohammadi S, Palermo A, Ojani P et al. Nutrients, 2026.PubMedFull paper
- Randomized trialOral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F Arch Med Res, 2014.PubMedFull paper
- Randomized trialNo positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study.Simental-Mendía LE, Rodríguez-Morán M, Reyes-Romero MA et al. Magnes Res, 2012.PubMedFull paper
- ReviewDietary Magnesium and Chronic Disease.Nielsen FH Adv Chronic Kidney Dis, 2018.PubMedFull paper
- ReviewGlobal Dietary Magnesium Deficiency: Prevalence, Underlying Causes, Health Consequences, and Strategic Solutions.Zhang W, Zhao Y Int J Vitam Nutr Res, 2025.PubMedFull paper
- ReviewMagnesium in man: implications for health and disease.de Baaij JH, Hoenderop JG, Bindels RJ Physiol Rev, 2015.PubMedFull paper
- Cross-sectionalDietary magnesium, C-reactive protein and interleukin-6: The Strong Heart Family Study.Rao ND, Lemaitre RN, Sitlani CM et al. PLoS One, 2023.PubMedFull paper
